HeraMED (ASX:HMD) onboarded more than 3,800 expectant mothers onto the HeraCARE maternity monitoring and management platform as of Sept. 30, according to a Tuesday filing with the Australian bourse.

The platform currently reached a new record of 710 expectant mothers, the filing stated.

The medical data and technology company attributed its growth to US-based Broward Health, which added 207 active users in its first 100 days of going live with HeraCARE.

HeraMED's shares were up nearly 5% in recent trade.

Price (AUD): $0.02, Change: $+0.00100, Percent Change: +4.76%